Overview

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

Status:
Completed

Trial end date:
2014-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the efficacy and safety of Innohep® in preventing the recurrence of VTE in patients with active cancer who have had an acute VTE episode.

Phase:

Phase 3

Details

Lead Sponsor:

LEO Pharma

Treatments:

Retinol palmitate
Tinzaparin
Vitamin A
Vitamin K
Warfarin